TuHURA Biosciences (HURA) Operating Expenses (2010 - 2026)
TuHURA Biosciences (HURA) posted quarterly Operating Expenses of $7.5 million for Q1 2026, up 7.31% year-over-year from $7.0 million in Q1 2025, and down 7.87% quarter-over-quarter from $8.2 million in Q4 2025.
TuHURA Biosciences (HURA) Operating Expenses (2010 - 2026) Analysis & Trends
TuHURA Biosciences' Operating Expenses history runs 17 years deep, the most recent figure standing at $7.5 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 7.31% year-over-year to $7.5 million; the TTM figure through Mar 2026 stood at $32.3 million (up 43.02% YoY), while the FY2025 annual figure was $31.8 million, up 80.15% from the prior year.
- Operating Expenses for Q1 2026 stood at $7.5 million, down from $8.2 million in the prior quarter.
- The five-year high for Operating Expenses was $12.0 million in Q3 2024, with the low at -$2.4 million in Q2 2023.
- The 5-year median for Operating Expenses is $5.4 million (2022), against an average of $5.5 million.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses soared 303.6% in 2024, then sank 43.71% in 2025.
- TuHURA Biosciences' Operating Expenses stood at $3.5 million in 2022, then advanced by 13.78% to $4.0 million in 2023, then jumped by 200.29% to $12.0 million in 2024, then slumped by 31.63% to $8.2 million in 2025, then retreated by 7.87% to $7.5 million in 2026.
- Business Quant data shows HURA's Operating Expenses at $7.5 million in Q1 2026, $8.2 million in Q4 2025, and $6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - | 8.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.53 Mn |
| Dec 31, 2025 | 8.17 Mn |
| Sep 30, 2025 | 6.73 Mn |
| Jun 30, 2025 | 9.88 Mn |
| Mar 31, 2025 | 7.02 Mn |
| Sep 30, 2024 | 11.95 Mn |
| Jun 30, 2024 | 3.62 Mn |
| Mar 31, 2024 | 6.07 Mn |
| Dec 31, 2023 | 3.98 Mn |
| Sep 30, 2023 | 2.96 Mn |
| Jun 30, 2023 | -2.43 Mn |
| Mar 31, 2023 | 3.30 Mn |
| Dec 31, 2022 | 3.50 Mn |
| Sep 30, 2022 | 4.65 Mn |
| Mar 31, 2022 | 5.36 Mn |
| Dec 31, 2021 | 5.90 Mn |
| Sep 30, 2021 | 5.97 Mn |
| Jun 30, 2021 | 6.70 Mn |
| Mar 31, 2021 | 6.61 Mn |
| Dec 31, 2020 | 5.38 Mn |